UCB (company)

Belgian multinational biopharmaceutical company

UCB logo

UCB S.A. is a multinational biopharmaceutical company headquartered in Brussels, Belgium. It specializes in the research, development, and commercialization of innovative medicines and solutions to improve the lives of people with severe diseases in the fields of neurology and immunology.

History

UCB was founded in 1928 by Emmanuel Janssen as a chemical company. Initially, it focused on industrial chemicals, but over the decades, it shifted its focus towards pharmaceuticals. The company made significant strides in the pharmaceutical industry in the 1950s and 1960s, leading to its current status as a leader in biopharmaceuticals.

Research and Development

UCB is committed to advancing scientific research and development. The company invests heavily in R&D, with a focus on discovering and developing new therapies for neurological disorders and autoimmune diseases. UCB's research facilities are located in several countries, including Belgium, the United States, and the United Kingdom.

Neurology

In the field of neurology, UCB has developed treatments for conditions such as epilepsy, Parkinson's disease, and restless legs syndrome. The company's flagship product in this area is levetiracetam, marketed under the brand name Keppra, which is used to treat epilepsy.

Immunology

UCB's immunology division focuses on developing therapies for autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. One of its notable products is certolizumab pegol, marketed as Cimzia, which is used to treat several inflammatory conditions.

Global Presence

UCB operates in over 40 countries worldwide, with major markets in Europe, North America, and Asia. The company employs thousands of people globally and collaborates with various academic and research institutions to advance its scientific goals.

Corporate Social Responsibility

UCB is committed to corporate social responsibility and sustainability. The company engages in various initiatives to reduce its environmental impact, promote ethical business practices, and support communities where it operates.

Related pages

• Biopharmaceutical
• Neurology
• Immunology
• Pharmaceutical industry